Prenatal therapy in transient abnormal myelopoiesis: a systematic review

Prenatal therapy in transient abnormal myelopoiesis: a systematic review

<p><strong>Objective</strong> To systematically review current evidence regarding prenatal diagnosis and management of transient abnormal myelopoiesis (TAM) in fetuses with trisomy 21. A novel case of GATA1-positive TAM, in which following serial in utero blood transfusion clinical...

Descrición completa

Detalles Bibliográficos
Main Authors:	Tamblyn, JA, Norton, A, Spurgeon, L, Donovan, V, Bedford Russell, A, Bonnici, J, Perkins, K, Vyas, P, Roberts, I, Kilby, MD
Formato:	Journal article
Idioma:	English
Publicado:	BMJ Publishing Group 2015

Títulos similares

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
por: Bhatnagar, N, et al.
Publicado: (2016)

Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
por: Roy, A, et al.
Publicado: (2012)

Transient abnormal myelopoiesis without constitutional Down syndrome
por: Kairiene, I, et al.
Publicado: (2019)

Transient abnormal myelopoiesis without constitutional Down syndrome
por: Igne Kairiene, et al.
Publicado: (2019-12-01)

Transient Abnormal Myelopoiesis in Down Syndrome
por: Ayesha Majeed, et al.
Publicado: (2017-01-01)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
por: Cruz Hernandez, D, et al.
Publicado: (2020)

Most haematological abnormalities in neonates with Down syndrome are transient but dysplastic myelopoiesis persists throughout early childhood
por: Hanssen, L, et al.
Publicado: (2019)

Down syndrome‐associated transient abnormal myelopoiesis with placental involvement
por: Yahya Daneshbod, et al.
Publicado: (2022-11-01)

Transient abnormal myelopoiesis: A case series and review of the literature
por: Vandana Baloda, et al.
Publicado: (2017-03-01)

Transient abnormal myelopoiesis with pericardial effusion in Down syndrome: Case report
por: Bianca Francisco Falasco, et al.
Publicado: (2019-07-01)

Transient Abnormal Myelopoiesis in a Down Syndrome Baby: A Case Report
por: Vani Krishnamurthy, et al.
Publicado: (2024-08-01)

Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports
por: Hui Tang, et al.
Publicado: (2023-10-01)

Phenotypic switching to hypereosinophilia during cytoreductive therapy for transient abnormal myelopoiesis associated with Down syndrome
por: Kenichiro Kobayashi, et al.
Publicado: (2022-05-01)

Clinical characterization and genetic analysis of transient abnormal myelopoiesis without the down syndrome phenotype
por: Junpeng Cai, et al.
Publicado: (2025-03-01)

Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis
por: Tadamune Kinjo, et al.
Publicado: (2019-08-01)

Hepatosplenomegaly Associated with Transient Abnormal Myelopoiesis in Down Syndrome: An Autopsy Case of a Stillborn Fetus
por: Michiko Yuki, et al.
Publicado: (2015-06-01)

Transient abnormal myelopoiesis with extramedullary involvement in a down syndrome preemie leading to an unresponsive course despite chemotherapy
por: Saroja Devi Geetha, et al.
Publicado: (2023-01-01)

Prenatal Diagnosis of 46,XX,der(13;21)(q10;q10),+21 and Transient Abnormal Myelopoiesis in a Fetus with Hepatosplenomegaly and Spontaneous Resolution of Fetal Ascites
por: Chih-Ping Chen, et al.
Publicado: (2009-03-01)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation
por: Yoko Nishinaka-Arai, et al.
Publicado: (2020-04-01)

Insights into Normal Myelopoiesis
por: Dennis G Osmond
Publicado: (1992-01-01)

Myelopoiesis and Myeloid Leukaemogenesis in the Zebrafish
por: A. Michael Forrester, et al.
Publicado: (2012-01-01)

Detection of transient abnormal myelopoiesis blasts in a liver biopsy specimen by double-immunostaining for full-length GATA1 and CD42b
por: Azusa Haba, et al.
Publicado: (2023-12-01)

Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis.
por: Hanumantha Rao Balaji Raghavendran, et al.
Publicado: (2012-01-01)

Identification of two distinct pathways of human myelopoiesis
por: Drissen, R, et al.
Publicado: (2019)

Myelopoiesis during Solid Cancers and Strategies for Immunotherapy
por: Tyler J. Wildes, et al.
Publicado: (2021-04-01)

A regulatory role for CHD2 in myelopoiesis
por: Farzaneh Shahin Varnoosfaderani, et al.
Publicado: (2020-07-01)

Zebrafish: a convenient tool for myelopoiesis research
por: Yang-Xi Hu, et al.
Publicado: (2023-01-01)

Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
por: Antonio Sica, et al.
Publicado: (2019-07-01)

The NOTCH pathway contributes to cell fate decision in myelopoiesis
por: Laurence Bugeon, et al.
Publicado: (2011-12-01)

Bone Marrow Myelopoiesis Independently of Canonical Notch Signaling
por: Duarte, S, et al.
Publicado: (2017)

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
por: Jonathan Rodriguez, et al.
Publicado: (2023-04-01)

Identification of Stromal Cells in Spleen Which Support Myelopoiesis
por: Hong Kiat Lim, et al.
Publicado: (2019-01-01)

Multi-omics characterization of human myelopoiesis at the single cell level
por: Tao, H
Publicado: (2024)

Hypothalamic-pituitary-derived melanocortin axis links to myelopoiesis and immunotherapy
por: Chao Zhang, et al.
Publicado: (2023-07-01)

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis.
por: Kelly M Arcipowski, et al.
Publicado: (2016-01-01)

Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice.
por: Annabelle Cesaro, et al.
Publicado: (2019-01-01)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
por: Roy, A, et al.
Publicado: (2009)

Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
por: Andrea Arleo, et al.
Publicado: (2024-11-01)

Infection with hypervirulent Mycobacterium tuberculosis triggers emergency myelopoiesis but not trained immunity
por: Ana Raquel Maceiras, et al.
Publicado: (2023-06-01)

Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis
por: Yaeko Nakajima-Takagi, et al.
Publicado: (2023-06-01)